immunai is building technology to revolutionize treatments of oncology and auto-immune disorders by combining the most cutting edge AI and novel biological assays to understand a person's immune system 10x better than previously possible. They have raised a substantial seed round, have several partnerships lined up with hospitals in the US and Israel, and are on path to amassing a substantial proprietary dataset.